In contrast, when TIGIT and/or CD155 upregulation predominates on immunosuppressive cell types—such as Tregs or TAMs—or on tumor cells themselves, it may reflect a more advanced state of immune escape and thus associate with poor prognosis. This evidence concerns the gene PVR and neoplasm.